Analysis Note
Positive ControlMCF7 cells
Application
Frozen Sections (see application reference)r>Immunoblotting (2 µg/ml)r>Immunofluorescence (see application reference)r>Immunoprecipitation (see application reference)r>Paraffin Sections (see application reference)
General description
Recognizes the ~220 kDa BRCA1 protein in MCF-7 cells. Does not cross-react with blood group antigens or growth factor receptors such as EGFR. Sold under license of U.S. Patent 5,753,441 and 6,162,897.
Purified mouse monoclonal antibody generated by immunizing mice with the specified immunogen and fusing splenocytes with NS1 mouse myeloma cells. Recognizes the ~220 kDa BRCA1 protein.
Anti-BRCA1 (Ab-1), mouse monoclonal, clone MS110, recognizes the ~220 kDa BRCA1 protein in MCF-7 cells. It is validated for WB, IF, IP, and frozen and paraffin sections.
Immunogen
recombinant human BRCA1
Epitope: within the N-terminal 304 amino acids of BRCA1
Human
Legal Information
Sold under license of U.S. Patents 5,753,441 and 6,162,897.
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Scully, R., et al. 1996. Science272, 123.Gudas, J.M., et al. 1996. Cell Growth Differ.7, 717.Vaughn, J.P., et al. 1996. Cell Growth Differ.7, 711.Goldgar, D.E. and Reilly, P.R. 1995. Nat. Genet.11, 113.Merajver, S.D., et al. 1995. Clin. Can. Res.1, 539.Merajver, S.D., et al. 1995. Nat. Genet.9, 439.Struewing, J.P., et al. 1995. Nat. Genet.11, 198.Thompson, M.E., et al. 1995. Nat. Genet.9, 444.Futreal, P.A., et al. 1994. Science266, 120.Miki, Y., et al. 1994. Science266, 66.Wilson, C.A., et al. 1999. Nat. Genet.21, 236.
Antibody should be titrated for optimal results in individual systems.
Packaging
100 µg in Plastic ampoule
Please refer to vial label for lot-specific concentration.
Physical form
In 50 mM sodium phosphate buffer, 0.2% gelatin, pH 7.5.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: